416 related articles for article (PubMed ID: 32187470)
41. Clinical manifestations, diagnosis, and treatment of hereditary angioedema: survey data from 94 physicians in Japan.
Ohsawa I; Honda D; Nagamachi S; Hisada A; Shimamoto M; Inoshita H; Mano S; Tomino Y
Ann Allergy Asthma Immunol; 2015 Jun; 114(6):492-8. PubMed ID: 25872948
[TBL] [Abstract][Full Text] [Related]
42. Hereditary angioedema: Repeated attacks in a 10-year-old boy.
Otani T; Hoshika S; Horiuchi T; Hashimura C; Sugihara S
Pediatr Int; 2019 Jan; 61(1):101-103. PubMed ID: 30734432
[No Abstract] [Full Text] [Related]
43. Hereditary cause of severe recurrent bowel swelling that requires targeted therapy.
Fernando SL; Li J
Med J Aust; 2014 Feb; 200(3):179. PubMed ID: 24528436
[No Abstract] [Full Text] [Related]
44. Managing the female patient with hereditary angioedema.
Banerji A; Riedl M
Womens Health (Lond); 2016 Jun; 12(3):351-61. PubMed ID: 26978558
[TBL] [Abstract][Full Text] [Related]
45. Uncommon Signs Associated With Hereditary Angioedema With Normal C1 Inhibitor.
Taya J; Veronez CL; Pesquero JB; Bork K; Grumach AS
J Investig Allergol Clin Immunol; 2021 Jun; 31(3):257-258. PubMed ID: 32732176
[No Abstract] [Full Text] [Related]
46. Hereditary Angioedema with Normal C1 Inhibitor: Update on Evaluation and Treatment.
Magerl M; Germenis AE; Maas C; Maurer M
Immunol Allergy Clin North Am; 2017 Aug; 37(3):571-584. PubMed ID: 28687110
[TBL] [Abstract][Full Text] [Related]
47. Time to response outcomes in hereditary angioedema.
Pullman W
Ann Allergy Asthma Immunol; 2011 Apr; 106(4):350; author reply 350-1. PubMed ID: 21457889
[No Abstract] [Full Text] [Related]
48. Prophylactic Therapy for Hereditary Angioedema.
Longhurst H; Zinser E
Immunol Allergy Clin North Am; 2017 Aug; 37(3):557-570. PubMed ID: 28687109
[TBL] [Abstract][Full Text] [Related]
49. Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema.
Zuraw BL; Busse PJ; White M; Jacobs J; Lumry W; Baker J; Craig T; Grant JA; Hurewitz D; Bielory L; Cartwright WE; Koleilat M; Ryan W; Schaefer O; Manning M; Patel P; Bernstein JA; Friedman RA; Wilkinson R; Tanner D; Kohler G; Gunther G; Levy R; McClellan J; Redhead J; Guss D; Heyman E; Blumenstein BA; Kalfus I; Frank MM
N Engl J Med; 2010 Aug; 363(6):513-22. PubMed ID: 20818886
[TBL] [Abstract][Full Text] [Related]
50. Successful C1 esterase inhibitor therapy in a child with a novel type 3 hereditary angioedema-like syndrome.
Rasmussen JL; Park MA; Fischer PR
Ann Allergy Asthma Immunol; 2012 Jun; 108(6):462-3. PubMed ID: 22626603
[No Abstract] [Full Text] [Related]
51. Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.
Zeerleder S; Levi M
Ann Med; 2016; 48(4):256-67. PubMed ID: 27018196
[TBL] [Abstract][Full Text] [Related]
52. Therapeutic agents for hereditary angioedema.
Giavina-Bianchi P; Motta A; Kalil J
N Engl J Med; 2011 Jan; 364(1):85; author reply 86. PubMed ID: 21208116
[No Abstract] [Full Text] [Related]
53. Outcomes of long term treatments of type I hereditary angioedema in a Turkish family.
Akoglu G; Kesim B; Yildiz G; Metin A
An Bras Dermatol; 2017; 92(5):655-660. PubMed ID: 29166502
[TBL] [Abstract][Full Text] [Related]
54. Real-life experience with long-term prophylactic C1 inhibitor concentrate treatment of patients with hereditary angioedema: Effectiveness and cost.
Rasmussen ER; Aagaard L; Bygum A
Ann Allergy Asthma Immunol; 2016 May; 116(5):476-7. PubMed ID: 27017563
[No Abstract] [Full Text] [Related]
55. Outcome measures in randomized controlled studies of acute therapy for hereditary angioedema: A systematic review.
Fijen LM; Petersen RS; Cohn DM
Allergy; 2022 Jul; 77(7):2222-2224. PubMed ID: 35122275
[No Abstract] [Full Text] [Related]
56. Safety of C1-inhibitor concentrate use for hereditary angioedema in pediatric patients.
Busse P; Baker J; Martinez-Saguer I; Bernstein JA; Craig T; Magerl M; Riedl M; Shapiro R; Frank M; Lumry W; Rosch J; Edelman J; Williams-Herman D; Feuersenger H; Rojavin M;
J Allergy Clin Immunol Pract; 2017; 5(4):1142-1145. PubMed ID: 28286153
[No Abstract] [Full Text] [Related]
57. sgp120 and the contact system in hereditary angioedema: A diagnostic tool in HAE with normal C1 inhibitor.
Larrauri B; Hester CG; Jiang H; Miletic VD; Malbran A; Bork K; Kaplan A; Frank M
Mol Immunol; 2020 Mar; 119():27-34. PubMed ID: 31955064
[TBL] [Abstract][Full Text] [Related]
58. Hereditary angioedema--therapies old and new.
Morgan BP
N Engl J Med; 2010 Aug; 363(6):581-3. PubMed ID: 20818894
[No Abstract] [Full Text] [Related]
59. Hereditary angioedema with normal C1 inhibitor: clinical characteristics and treatment response with plasma-derived human C1 inhibitor concentrate (Berinert
Bouillet L; Boccon-Gibod I; Gompel A; Floccard B; Martin L; Blanchard-Delaunay C; Launay D; Fain O
Eur J Dermatol; 2017 Apr; 27(2):155-159. PubMed ID: 28251901
[TBL] [Abstract][Full Text] [Related]
60. A Decade of Change: Recent Developments in Pharmacotherapy of Hereditary Angioedema (HAE).
Bork K
Clin Rev Allergy Immunol; 2016 Oct; 51(2):183-92. PubMed ID: 27207174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
